First Hawaiian Bank Vertex Pharmaceuticals Inc Transaction History

First Hawaiian Bank

$3.05 Billion
Q3 2024

A detailed history of First Hawaiian Bank transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, First Hawaiian Bank holds 4,106 shares of VRTX stock, worth $1.92 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,106

Previous 3,322 23.6%

Holding current value

$1.92 Million

Previous $1.56 Million 22.61%

% of portfolio

0.06%

Previous 0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$460.0 - $505.78 $360,640 - $396,531	784 Added 23.6%	4,106 $1.91 Million
Q2 2024 Jul 02, 2024	SELL	$392.81 - $485.53 $125,699 - $155,369	-320 Reduced 8.79%	3,322 $1.56 Million
Q1 2024 Apr 05, 2024	SELL	$407.69 - $446.08 $320,036 - $350,172	-785 Reduced 17.73%	3,642 $1.52 Million
Q4 2023 Jan 08, 2024	BUY	$343.0 - $410.68 $193,109 - $231,212	563 Added 14.57%	4,427 $1.8 Million
Q3 2023 Oct 10, 2023	SELL	$338.18 - $362.46 $77,443 - $83,003	-229 Reduced 5.59%	3,864 $1.34 Million
Q2 2023 Jul 06, 2023	SELL	$314.42 - $351.91 $571,301 - $639,420	-1,817 Reduced 30.74%	4,093 $1.44 Million
Q1 2023 Apr 18, 2023	SELL	$283.23 - $323.1 $34,837 - $39,741	-123 Reduced 2.04%	5,910 $1.86 Million
Q4 2022 Jan 12, 2023	SELL	$285.76 - $321.48 $26,004 - $29,254	-91 Reduced 1.49%	6,033 $1.74 Million
Q3 2022 Oct 05, 2022	BUY	$273.83 - $305.53 $152,797 - $170,485	558 Added 10.03%	6,124 $1.77 Million
Q2 2022 Jul 22, 2022	BUY	$234.96 - $292.55 $650,604 - $810,070	2,769 Added 99.0%	5,566 $1.57 Million
Q4 2021 Jan 12, 2022	BUY	$177.01 - $223.45 $495,096 - $624,989	2,797 New	2,797 $614,000
Q4 2020 Jan 12, 2021	SELL	$207.01 - $276.09 $1.32 Million - $1.76 Million	-6,379 Closed	0 $0
Q3 2020 Oct 06, 2020	SELL	$255.65 - $303.1 $38,347 - $45,465	-150 Reduced 2.3%	6,379 $1.74 Million
Q2 2020 Aug 05, 2020	SELL	$225.48 - $295.8 $330,553 - $433,642	-1,466 Reduced 18.34%	6,529 $1.9 Million
Q1 2020 Apr 21, 2020	BUY	$199.77 - $247.81 $551,964 - $684,699	2,763 Added 52.81%	7,995 $1.9 Million
Q4 2019 Jan 13, 2020	BUY	$166.71 - $223.91 $242,229 - $325,341	1,453 Added 38.45%	5,232 $1.15 Million
Q3 2019 Oct 03, 2019	SELL	$166.23 - $187.09 $3,324 - $3,741	-20 Reduced 0.53%	3,779 $640,000
Q2 2019 Jul 15, 2019	SELL	$164.61 - $190.37 $602,472 - $696,754	-3,660 Reduced 49.07%	3,799 $696,000
Q1 2019 Apr 02, 2019	BUY	$163.73 - $194.7 $714,681 - $849,865	4,365 Added 141.08%	7,459 $1.37 Million
Q4 2018 Jan 11, 2019	BUY	$151.91 - $192.21 $75,955 - $96,105	500 Added 19.28%	3,094 $513,000
Q3 2018 Oct 16, 2018	BUY	$167.73 - $192.74 $435,091 - $499,967	2,594 New	2,594 $500,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.

Account

First Hawaiian Bank Vertex Pharmaceuticals Inc Transaction History